Best Compounded GLP-1 Telehealth Providers of 2026
Compare reviewed GLP-1 weight loss providers, billing commitments, and the treatments their links actually offer.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Compare the options first
Full comparison & price terms ↓A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.
$49/mo
Lower listed rate · not necessarily monthly billing
Semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month.
The Ranking
WellMedr
Compounded GLP-1 care with semaglutide shown at $49/mo or tirzepatide at $89/mo with 12-month prepayment; $99/$129 month to month. Verified affiliate coverage is weight loss only.
Editor’s take: WellMedr is our featured value-led compounded GLP-1 option, not a recommendation for unrelated men's-health or hair-loss treatment. Its public Trustpilot profile displayed 4.6/5 from 1,963 reviews when checked September 27, 2026; customer opinions do not establish clinical effectiveness. Recorded price terms were semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month. Compounded medications are not FDA-approved finished drugs. Confirm the exact prescription, pharmacy, dose progression, cancellation terms, and total commitment with the clinician before paying.
Full review →Hone Health
Hormone optimisation platform with real biomarker testing and physician-guided protocols, for men and women.
Editor’s take: If you take hormone health seriously and you're willing to pay for biomarker testing, Hone is the most clinically credible option in this list. If you only want low-friction TRT and you're price-sensitive, Peter MD or DudeMeds will fit better.
Full review →SkinnyRx
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Editor’s take: Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.
Full review →NewSelf
Industry-low flat-dose pricing on compounded semaglutide and tirzepatide — all dosages, one price, no membership fee.
Editor’s take: One of the most aggressively priced compounded GLP-1 clinics on the market. Flat-dose pricing is a genuine differentiator — you won't pay more as your dose increases. Customer service responsiveness has been flagged in some reviews; verify support quality before committing to a long-term plan.
Full review →bmiMD
Plan-length-priced compounded semaglutide with optional longevity add-ons and online clinician access.
Editor’s take: The current semaglutide ladder is easy to compare when you separate the $129 month-to-month option from the lower long-term rates. Do not assume that price applies to tirzepatide, higher doses, or optional add-ons; verify the checkout total before committing.
Full review →Eden
Flat upfront pricing with the same dose-equal cost across both compounded and brand-name GLP-1s.
Editor’s take: A genuinely buyer-friendly pricing model. Eden also has the deepest longevity menu of any GLP-1-led clinic on this list: methylene blue and GHK-Cu are not common.
Full review →Yucca Health
Provider-guided care from US-licensed pharmacies, covering GLP-1, NAD+, and recovery-focused peptides.
Editor’s take: A solid recovery-and-longevity-leaning GLP-1 clinic. If you want a pure, lowest-cost compounded GLP-1, you can pay less elsewhere, but the recovery angle is genuinely differentiated. If you want a pure, lowest-cost compounded GLP-1 without the longevity framing, you can pay less elsewhere. The recovery and longevity add-ons are the main reason to choose Yucca Health over a cheaper GLP-1 specialist.
Full review →Sesame Care
Cash-pay telehealth marketplace with transparent per-visit pricing and Costco-member discounts.
Editor’s take: A flat-fee marketplace that earns its place when you only need a single transparent visit. Sustained GLP-1 buyers may prefer a dedicated specialty clinic. If you want a sustained GLP-1 program with ongoing provider support, a dedicated GLP-1 clinic will offer better continuity than Sesame's per-visit marketplace model.
Full review →Direct Meds
Compounded GLP-1 clinic with transparent pricing and dedicated nurse support.
Editor’s take: Direct Meds is easier to compare than a program that separates its membership fee from medication, provided the public $249 and $297 starting points match the treatment path you are offered. Skip it if you specifically want brand-name GLP-1 access or in-state pickup.
Full review →Shed Rx
GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.
Editor’s take: A reasonable mid-priced pick when delivery flexibility matters. Verify auto-billing terms before signing up given mixed reports. Verify auto-billing terms before signing up given mixed reviews on cancellation. If delivery flexibility is your priority, compare ShedRx against Breeze Meds which also offers sublingual tirzepatide.
Full review →Rugiet
Men's performance medicine platform with a proprietary 3-in-1 sublingual ED treatment (sildenafil + tadalafil + apomorphine), TRT, sleep Rx, and GLP-1 weight loss.
Editor’s take: The most differentiated ED product in the telehealth market. The 3-in-1 sublingual formula is genuinely novel, and the multi-category platform (TRT, sleep, GLP-1) makes Rugiet a strong single-provider option for men managing multiple health goals.
Full review →Women-focused telehealth combining compounded GLP-1 weight loss with HRT support.
Editor’s take: A focused women's health pick. If you only want GLP-1, you'll find cheaper; if you want both GLP-1 and HRT in one clinic, this is one of the cleanest options on the list. If you only want GLP-1 without hormonal support, a lower-cost specialist like Trimi or HealthRx will be more cost-effective. If you want both GLP-1 and HRT in one clinic, Gala Health is one of the cleanest options available.
Full review →2026 Price Comparison. Published Price Terms
Compare the lower and higher listed rates, then read the billing conditions. A listed monthly equivalent may require prepayment; visits, medication, membership, or shipping can cost extra.
Recorded price-check dates: 13 July 2026 – 11 August 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
6 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| WellMedr Semaglutide $49/mo or tirzepatide $89/mo with 12-month prepayment; $99/$129 month to month. | Lower listed rate$49/mo | Higher listed rate$99 – $129/mo | Pharmacy503A | 4.6/5 1,963 reviews 11 August 2026 | Go WellMedrRead full review |
| SkinnyRx | Lower listed rate$149/mo | Higher listed rate$249/mo | Pharmacy503A | 4.8/5 5,335 reviews Check current price | Go SkinnyRxRead full review |
| FuturHealth Includes coaching | Lower listed rate$198/mo | Higher listed rate$299/mo | Pharmacy503A | 4.7/5 15,774 reviews Check current price | Go FuturHealthRead full review |
| Shed Rx | Lower listed rate$199/mo | Higher listed rate$299/mo | Pharmacy503A | 4.7/5 956 reviews Check current price | Go Shed RxRead full review |
| TrimiLowest Flat Rate Flat rate at every dose | Lower listed rate$99/mo | Higher listed rate$125/mo | Pharmacy503A | 4.7/5 Check current price | Go TrimiRead full review |
| Telos Rx First-month pricing on longer plans | Lower listed rate$49/mo | Higher listed rate$199/mo | Pharmacy503A | 4.9/5 3 reviews 13 July 2026 | Go Telos RxRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
What to know before choosing
Compounded GLP-1s, semaglutide and tirzepatide mixed by 503A or 503B compounding pharmacies, remain the most affordable on-ramp to the GLP-1 category in 2026. The FDA's 2024 ruling closed the official tirzepatide shortage, which means compounding now operates under the personalisation exception (a clinician must document a clinical justification, such as dose customisation, the addition of B12, or a documented intolerance to an inactive ingredient in the brand-name product). Pricing, pharmacy licensure, and formulation breadth still vary widely between providers. We compared every clinic in our network that ships a compounded GLP-1, and ranked the ones with the strongest combination of pharmacy transparency, real clinical oversight, and price predictability.
Compounded GLP-1s — semaglutide and tirzepatide prepared by 503A or 503B compounding pharmacies — became the dominant low-cost access pathway to GLP-1 therapy during the 2022–2025 drug shortage period. The FDA removed tirzepatide from the shortage list in October 2024 and declared the semaglutide shortage resolved in February 2025, with the compounding transition periods ending in April (503A) and May (503B) 2025. As of mid-2026, compounding is still legally available under the personalisation exception — a prescriber must document a clinical justification such as dose customisation, addition of B12, or a documented intolerance to an inactive ingredient in the brand-name product.
The quality gap between compounding providers is significant. The best providers use FDA-registered 503B outsourcing facilities with USP 797 sterility documentation and named pharmacy partners. The worst use unnamed 503A compounders with no public quality documentation. Pricing ranges from $80–$350/month depending on dose, provider, and whether the formulation includes add-ins like B12 or L-carnitine.
We compared every clinic in our network that ships a compounded GLP-1 and ranked the ones with the strongest combination of pharmacy transparency, real clinical oversight, and price predictability. Brand-name GLP-1 access was not weighted — this list is specifically about compounded quality.
Methodology
Each provider was scored on four axes: (1) compounded formulary breadth (injectable, oral, sublingual, lozenge, microdose), (2) price-per-mg transparency at every dose tier, (3) pharmacy disclosure (503A vs 503B, named partner, USP-797 sterility documentation), and (4) clinical oversight depth (real video visits vs async-only, prescriber state coverage, follow-up cadence). Brand-name access was not weighted, this list is specifically about compounded GLP-1 quality, not Wegovy or Zepbound availability.
Compounded GLP-1: The Regulatory Landscape and What It Means for You
Compounded semaglutide and tirzepatide have been the dominant form of GLP-1 telehealth for the past two years. The regulatory situation is shifting, and patients starting a compounded protocol today are taking on more uncertainty than patients who started in 2023. Here is what you need to understand.
The Shortage List and Why It Matters
Under section 503A of the FD&C Act, traditional compounding pharmacies can prepare copies of FDA-approved drugs only when those drugs appear on the FDA's drug-shortage list. Semaglutide and tirzepatide were added to the shortage list in 2022 and 2023 respectively, which is what made the compounded GLP-1 telehealth market possible at scale.
The FDA has been removing these drugs from the shortage list as supply normalizes. Once a drug is removed, the 503A pathway for compounded copies narrows significantly — compounding is still permitted for individual patient needs (specific allergies, dosing requirements) but not for general commercial distribution. This means the compounded GLP-1 you start today may not be available in the same form in 6–12 months.
503A vs 503B: Why the Pharmacy Type Matters
503A pharmacies are traditional compounding pharmacies that prepare medications for individual patients based on a prescription. They are not FDA-registered and are not subject to FDA manufacturing inspections. 503B outsourcing facilities are FDA-registered, subject to cGMP manufacturing standards, and can produce larger batches for distribution to healthcare providers.
For patients, the practical difference is quality assurance. 503B facilities have demonstrated manufacturing controls; 503A facilities have not been independently verified. The FDA has issued warning letters to multiple 503A pharmacies for contamination, mislabeling, and potency issues with compounded semaglutide. Clinics that use 503B-sourced compounded GLP-1s are operating at a higher quality bar.
What to Ask Before Signing Up
Before starting a compounded GLP-1 protocol, ask the clinic: Is the medication sourced from a 503A or 503B pharmacy? What is the pharmacy's name? Does the formulation include any additives (B12, L-carnitine, etc.) and if so, why? What is the clinic's contingency plan if the shortage list status changes?
Clinics that cannot or will not answer these questions clearly are not operating with the transparency that a long-term medication protocol requires.
Compounded GLP-1 therapy is a legitimate option for patients who cannot access or afford brand-name Wegovy or Zepbound — but it comes with regulatory uncertainty that brand-name therapy does not. The clinics in our top tier above are transparent about their pharmacy sourcing and have contingency plans for regulatory changes.
What the Studies Actually Show
Compounded GLP-1s contain the same active ingredient as Wegovy / Ozempic (semaglutide) or Zepbound / Mounjaro (tirzepatide). They have not themselves been studied in randomised trials; efficacy is inferred from the trials of the underlying API, summarised below.
| Endpoint | Finding |
|---|---|
| Mean weight loss (STEP 1, 68 weeks, 2.4 mg)1 | −14.9% body weight vs −2.4% placebo in adults with overweight/obesity without diabetes |
| Cardiovascular outcomes (SELECT, ~40 months)2 | 20% relative risk reduction in major adverse cardiovascular events (MACE) in adults with established CV disease and overweight/obesity |
| GI side effects (FDA prescribing information)3 | Nausea ≥10%, diarrhea ≥10%, vomiting ≥10%, constipation ≥10%; most cases mild–moderate and dose-dependent |
| Boxed warning3 | Risk of thyroid C-cell tumors observed in rodent studies; contraindicated in personal/family history of MTC or MEN 2 |
| Mean weight loss (SURMOUNT-1, 72 weeks, 15 mg)6 | −20.9% body weight vs −3.1% placebo in adults with obesity without diabetes |
| Mean weight loss with T2D (SURMOUNT-2, 72 weeks, 15 mg)7 | −14.7% body weight in adults with type 2 diabetes |
| Sleep apnea (SURMOUNT-OSA)8 | Tirzepatide reduced apnea-hypopnea index (AHI) by ~25–29 events/hour vs placebo at 52 weeks; FDA-approved labeling for moderate-to-severe OSA in obesity |
Frequently Asked Questions
Are compounded GLP-1s legal in 2026?
Yes, compounded GLP-1s remain legal under the FDA's personalisation exception. After the 2024 ruling that ended the official tirzepatide and semaglutide shortages, compounding is permitted only when a licensed clinician documents a clinical justification, such as a customised dose, the addition of vitamin B12, or a documented allergy to an inactive ingredient in the brand-name product. Reputable providers include this documentation in their intake.
What's the difference between 503A and 503B compounding pharmacies?
503A pharmacies compound on a per-prescription basis for an individual patient and are state-licensed. 503B outsourcing facilities are FDA-registered, follow CGMP standards, and can produce larger batches, generally considered the higher-tier sterility option for injectables. Some providers (Eden, Henry Meds, Mochi) use 503B partners and disclose it. Always ask which pharmacy fulfils your script.
Is compounded semaglutide as effective as Wegovy?
Compounded semaglutide uses the same active ingredient as Wegovy and Ozempic. Real-world outcomes are broadly comparable when sourced from a licensed compounding pharmacy with verified API. The variable is sterility and formulation consistency, which is why pharmacy licensure (503A vs 503B) matters. Compounded products are not FDA-approved as finished drugs.
What's the cheapest compounded GLP-1 telehealth provider in 2026?
Within our network, Wellorithm, Mochi, and Eden consistently lead on price-per-mg, with starting plans from $149 to $199 per month including provider visits. The actual cheapest option depends on your starting dose. Some clinics charge flat rates regardless of dose (TMates, Wellorithm), while others surcharge as you titrate up.
Do compounded GLP-1s come with B12?
Some do, some don't. Compounded semaglutide-with-B12 and tirzepatide-with-B12 are common formulations because the addition of B12 is one of the documented clinical justifications under the personalisation exception. Hims, Eden, Henry Meds, and Mochi explicitly offer B12-bundled formulations.
- STEP 1 — NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
- SELECT — NEJM 2023 · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389:2221–2232.
- SURMOUNT-1 — NEJM 2022 · Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022;387:205–216.
- SURMOUNT-2 — Lancet 2023 · Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 2023;402(10402):613–626.
- SURMOUNT-OSA — NEJM 2024 · Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med 2024;391:1193–1205.
- SURPASS — program summary · Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med 2021;385:503–515.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
Compare Top Providers
- bmiMD vs SkinnyRx (2026): Which Compounded GLP-1 Clinic Wins?
- bmiMD vs Direct Meds (2026): Compounded GLP-1 Clinic Comparison
- SkinnyRx vs Shed Rx (2026): Which GLP-1 Clinic Is Right for You?
- Tonik vs bmiMD (2026): Full-Stack Clinic vs Low-Cost Entry
- bmiMD vs FuturHealth (2026): Compounded GLP-1 Clinic Comparison
- TrimRx vs SkinnyRx (2026): Brand-Name Access vs Oral GLP-1 Options
- SkinnyRx vs FuturHealth (2026): Oral GLP-1 vs Coaching-First Platform
- Shed Rx vs bmiMD (2026): Which Budget GLP-1 Clinic Wins?
- Breeze Meds vs bmiMD (2026): Sublingual GLP-1 vs Standard Injectable